NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

There is a huge and fundamental difference between cvm and nwbo in terms of MOA of cvm's failed Multikine and nwbo's dcvax-L.

Multikine is an immune booster designed to boost a patient's immune system before SOC treatment aimed to improve OS, quality of life, etc. just like grandma's chicken soup, while DCVax-L is not only an immune booster but more importantly "a cancer killing machine/system" loaded with patients' specific antigens, designed to seek, find and kill cancer cells.

CVM: CEO has constantly pumped the stock via social media and shareholder letters; the slim advantages (10% better than SOC) designed being very consistent to repeated failed previous trials for other indications (so aimed and fine-tuned to achieve "a lucky" success); one week before TLD a huge financing.

NWBO, CEO has behaved completely differently.

You buy nwbo -- a winning strategy

Don't touch cvm yet -- a winning strategy

[and Linda is dare enough to have dcvax trial results reviewed and analyzed by a panel of independent GBM experts!!!!]

[so the otcx pig is still on this one as of 9:38am 29 June]